SLU‑PP‑332 Oral – 500mcg

£75.00

Oral research format for simulated stability/solubility work.

SKU: PERM-SLUPP332-O500 Category: Tags: , ,
Description

Permagainz SLU-PP-332 is a novel research compound supplied strictly for in-vitro and laboratory use only.

It is a PPARβ/δ (Peroxisome Proliferator-Activated Receptor Beta/Delta) agonist analogue, studied primarily for its role in metabolic regulation, energy homeostasis, and mitochondrial function.

Each vial contains 5 mg of analytically verified SLU-PP-332, produced in ISO-accredited clean-room facilities to ensure exceptional purity, reproducibility, and scientific reliability.


Chemical Background / Research Profile

SLU-PP-332 is a synthetic small-molecule compound designed to interact selectively with PPARβ/δ nuclear receptors, which regulate genes responsible for fatty acid oxidation, glucose metabolism, and energy expenditure.
It serves as a modern research alternative to compounds such as GW-501516 (Cardarine), offering a refined chemical structure for the study of PPAR activation and transcriptional control in metabolic pathways.

In laboratory research, SLU-PP-332 is used to:

  • Investigate PPARβ/δ receptor binding and ligand-induced gene expression.

  • Study oxidative metabolism, lipid utilisation, and cellular energy regulation.

  • Examine mitochondrial biogenesis and metabolic efficiency under controlled in-vitro conditions.

  • Explore ligand selectivity and signal-transduction pathways involved in nuclear receptor activation.

Its targeted receptor selectivity and high metabolic stability make SLU-PP-332 a valuable compound for molecular pharmacology, biochemistry, and cellular metabolism research.


Purity and Quality Assurance

Permagainz SLU-PP-332 is manufactured to ≥ 98 % purity, confirmed by High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) analysis.
All production follows Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) within ISO-certified facilities.
Each vial is sterile-sealed and accompanied by a Certificate of Analysis (CoA) confirming purity, molecular structure, batch number, and expiry date for full traceability.


Laboratory Handling and Storage

  • Store at 20–25 °C in a dry, dark environment.

  • Protect from light, heat, and moisture.

  • Reconstitute using appropriate analytical-grade solvents under aseptic laboratory conditions.

  • Avoid repeated freeze–thaw cycles and contamination.

  • Dispose of unused material according to institutional COSHH and chemical-safety procedures.

Researchers must wear PPE (gloves, coat, and protective eyewear) and work in authorised laboratory environments.


Safety, Compliance and Restrictions

SLU-PP-332 is not a medicinal product, not approved for human or veterinary use, and must not be consumed, injected, or used for therapeutic or diagnostic purposes.
It is supplied solely for scientific and in-vitro research.

Permagainz complies fully with MHRA, REACH, and COSHH regulations covering the lawful handling of non-medicinal research materials.
All products are batch-tested, documented, and traceable, ensuring ethical and professional use within laboratory settings.

Through precise synthesis, verified purity, and transparent documentation, Permagainz provides SLU-PP-332 5 mg as a dependable research compound for studies into PPAR receptor biology, metabolic regulation, and molecular signalling mechanisms.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “SLU‑PP‑332 Oral – 500mcg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.